OWLT
Medical Devices · Healthcare
Board Member, Chairman, CEO
2022-09-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Owlet, Inc. publishes a filing, an earnings call transcript or a press release.
Get OWLT alertsKurt Workman is recorded as Board Member at Owlet, Inc. (OWLT) since August 12, 2026, Chairman at Owlet, Inc. (OWLT) since October 1, 2025 and CEO at Owlet, Inc. (OWLT) since September 1, 2022. Owlet, Inc. reported in an 8-K filed April 6, 2026 that Kurt Workman was appointed President and Chief Executive Officer, effective April 6, 2026. Owlet, Inc. reported in an 8-K filed October 6, 2025 that Kurt Workman was appointed Executive Chair of the Board, effective October 1, 2025. Owlet, Inc. reported in an 8-K filed October 6, 2025 that Kurt Workman resigned as Chief Executive Officer, effective October 1, 2025. Equibles holds 6 filed executive changes naming Kurt Workman; each is listed under recent activity with its source filing. The proxy statement of Owlet, Inc. reports total compensation of $799,405 for Kurt Workman in fiscal 2025, including a base salary of $300,000. Disclosed compensation is on record for 4 fiscal years. Kurt Workman has spoken on 19 earnings calls and 1 other investor event across 1 company, most recently for Owlet, Inc. on August 12, 2026. Owlet, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Owlet, Inc. includes Jonathan Harris (CEO), Lior Susan (Chairman and Board Member), Kathryn R. Scolnick (CFO) and 7 others.
“On April 3, 2026, the Board of Directors (the “Board”) of the Owlet, Inc. (the “Company”) appointed Kurt Workman as President and Chief Executive Officer effective April 6, 2026 (the “Effective Date”) to succeed Jonathan Harris in these positions.”
“effective October 1, 2025 (the "Effective Date"), Kurt Workman resigned as Chief Executive Officer of Owlet, Inc. (the "Company") and transitioned to the role of Executive Chair of the Board of Directors (the "Board").”
“On behalf of the directors and officers of the company, it's my pleasure to welcome you to our 2026th Annual Meeting of Stockholders, which I will now call to order.”
“Every day, Owlet is evolving more and more into a data and services platform for the earliest years of a child's life. Our products capture meaningful and unique information about a baby's sleep and health, turning that data into insights, guidance, and peace of mind for parents.”
“Before we dive into the business results, I want to address a recent leadership transition and a renewed path forward for Allis. On behalf of the board and the entire Allis team, I'd like to share our deep gratitude for Jonathan Harris.”
“Hello, everyone, and thank you for joining our second quarter 2025 financial results call today. I'm proud to report Q2 was another exceptional quarter for Owlet.”
“As you saw from our earnings release, we had a fantastic start to 2025 with strong results we announced today, reflecting the ongoing momentum we are driving as a business.”
2026-08-12–present
2025-10-01–present
2022-09-01–present
2022-09-01–2025-10-01
Start not stated–2025-10-01
OWLT
Medical Devices · Healthcare
Board Member, Chairman, CEO
2022-09-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Owlet, Inc. (OWLT) | President and Chief Executive Officer | $300,000 | $799,405 |
| 2024 | Owlet, Inc. (OWLT) | Chief Executive Officer | $375,000 | $987,073 |
| 2022 | Owlet, Inc. (OWLT) | President & Chief Executive Officer | $369,231 | $4,681,017 |
| 2021 | Owlet, Inc. (OWLT) | President & Chief Executive Officer | $329,808 | $1,764,178 |